FREE GUIDE + PARTNER DISCOUNTS
GET THE BIOHACKER'S RESEARCH GUIDE FREE
How to read a peptide study, a COA and a vendor page before you trust any of them. You also get exclusive reader discounts with our partners and the newsletter that reads the study before the headline.
Free. Lands in your inbox in about a minute. Join 14,000+ readers.
14,000+
NEWSLETTER READERS
59%
AVERAGE OPEN RATE
100K+
FOLLOWING ON INSTAGRAM
2×
ISSUES A WEEK, FREE
START HERE
THREE FREE TOOLS. PICK ONE.
01
THE BIOHACKER'S RESEARCH GUIDE
The reader favorite. How to read a peptide study, a COA and a vendor page before you trust any of them.
Get the guide →02
THE PEPTIDE CHEAT SHEET
25 peptides on one page, and who each one was actually tested on.
Get the sheet →03
THE BLOODWORK BASELINE
DM LABS to @biohackernetwork on Instagram, answer a few quick questions, and get the lab checklist built for your goal.
DM LABS on Instagram →LIVE TRACKER · UPDATED OCT 12, 2026
TWELVE PEPTIDES CAME OFF THE FDA'S DO-NOT-COMPOUND LIST. NONE OF THEM ARE LEGAL TO COMPOUND.
What changed on April 15, where each of the twelve actually sits right now, and the paperwork nobody selling you these is mentioning.
Open the tracker →PEPTIDE
STATUS
BPC-157
PANEL VOTED YES · NOT ON BULKS LIST
TB-500
PANEL VOTED YES · NOT ON BULKS LIST
GHK-Cu
NOT REVIEWED YET
LL-37
NOT REVIEWED YET
8 more on the full tracker.
PICK YOUR RABBIT HOLE
BROWSE BY TOPIC
Peptide Basics
Protocols, stacking, timing, reconstitution and reading a COA. Start here if you're new.
GLP-1s
Retatrutide, tirzepatide, semaglutide, and what the trials actually tested.
GH Axis
Tesamorelin, CJC, ipamorelin, sermorelin and how the growth hormone axis works.
Repair
BPC-157, TB-500, KPV, GHK-Cu and the repair-signaling research behind them.
Bloodwork
Lab panels, markers, and what the numbers are actually telling you.
FDA & RUO
FDA votes, compounding status, warning letters, supply and the paperwork behind research-use-only.
Foundations
Sleep, training, metabolic health, longevity and the basics everything else sits on.
THE NETWORK
THE CONVERSATION KEEPS GOING IN DISCORD.
Daily drops, vetted vendor channels, and people comparing notes on the same research you're reading.